G. Puliyath and M. K. Nair, Endometrial stromal sarcoma: A review of the literature, Indian J. Med. Paediatr. Oncol, vol.33, pp.1-6, 2012.

V. Y. Jo and C. D. Fletcher, WHO classification of soft tissue tumours: An update based on the, Pathology, vol.46, pp.95-104, 2013.

J. I. Koontz, A. L. Soreng, M. Nucci, F. C. Kuo, P. Pauwels et al., Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors, Proc. Natl. Acad. Sci, vol.98, pp.6348-6353, 2001.

C. Lee, W. Ou, A. Mariño-enriquez, M. Zhu, M. Mayeda et al., 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma, Proc. Natl. Acad. Sci, vol.109, pp.929-934, 2012.

F. Amant, A. Floquet, M. Friedlander, G. Kristensen, S. Mahner et al., Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma, Int. J. Gynecol. Cancer, vol.24, pp.67-72, 2014.

M. Meurer, A. Floquet, I. Ray-coquard, F. Bertucci, M. Auriche et al., Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: A retrospective series of the French Sarcoma Group, Int. J. Gynecol. Cancer, vol.29, pp.691-698, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02530373

P. G. Casali, N. Abecassis, H. T. Aro, S. Bauer, R. Biagini et al., Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.29, pp.51-67, 2018.

F. Micci, I. Panagopoulos, B. Bjerkehagen, and S. Heim, Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma, Cancer Res, vol.66, pp.107-112, 2006.

F. Micci, M. Brunetti, P. Dal-cin, M. R. Nucci, L. Gorunova et al., Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma, Genes Chromosomes Cancer, vol.56, pp.841-845, 2017.

F. Micci, L. Gorunova, S. Gatius, X. Matias-guiu, B. Davidson et al., Panagopoulos, I. MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma, Cancer Lett, vol.347, pp.75-78, 2014.

N. Lewis, R. A. Soslow, D. F. Delair, K. J. Park, R. Murali et al., ZC3H7B-BCOR high-grade endometrial stromal sarcomas: A report of 17 cases of a newly defined entity, Mod. Pathol, vol.31, pp.674-684, 2018.

A. Mariño-enriquez, A. Lauria, J. Przybyl, T. L. Ng, M. Kowalewska et al., BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas, Am. J. Surg. Pathol, vol.42, pp.335-341, 2018.

A. J. Allen, S. M. Ali, K. Gowen, J. A. Elvin, and T. Pejovic, A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1, Gynecol. Oncol. Rep, vol.20, pp.51-53, 2017.

B. C. Dickson, T. J. Childs, T. J. Colgan, Y. Sung, D. Swanson et al., Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions, Am. J. Surg. Pathol, vol.43, pp.178-186, 2019.

M. Brunetti, I. Panagopoulos, L. Gorunova, B. Davidson, S. Heim et al., RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma

, Genes Chromosomes Cancer, vol.57, pp.176-181, 2018.

B. Dewaele, J. Przybyl, A. Quattrone, J. Finalet-ferreiro, V. Vanspauwen et al., Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma, Int. J. Cancer, vol.134, pp.1112-1122, 2014.

S. Chiang, C. Lee, C. J. Stewart, E. Oliva, L. N. Hoang et al., BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology, Mod. Pathol, vol.30, pp.1251-1261, 2017.

S. Chiang, P. Cotzia, D. M. Hyman, A. Drilon, W. D. Tap et al., NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma, Am. J. Surg. Pathol, vol.42, pp.791-798, 2018.

C. M. Conklin and T. A. Longacre, Endometrial stromal tumors: The new WHO classification, Adv. Anat. Pathol, vol.21, pp.383-393, 2014.

P. Pautier, E. J. Nam, D. M. Provencher, A. L. Hamilton, G. Mangili et al.,

, Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus, Int. J. Gynecol. Cancer, vol.24, pp.73-77, 2014.

V. P. Sumathi, M. Al-hussaini, L. E. Connolly, L. Fullerton, and W. G. Mccluggage, Endometrial stromal neoplasms are immunoreactive with WT-1 antibody, Int. J. Gynecol. Pathol, vol.23, pp.241-247, 2004.

M. Pujani, Z. S. Jairajpuri, S. Rana, S. Jetley, M. J. Hassan et al., Cellular leiomyoma versus endometrial stromal tumor: A pathologists' dilemma, J. Midlife Health, vol.6, pp.31-34, 2015.

A. Valkov, S. Sorbye, T. K. Kilvaer, T. Donnem, E. Smeland et al., Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas, Int. J. Oncol, vol.38, pp.1031-1040, 2011.

O. Aisagbonhi, B. Harrison, L. Zhao, R. Osgood, I. Chebib et al., YWHAE Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing, Int. J. Gynecol. Pathol, vol.37, pp.441-447, 2018.

P. A. Cassier, A. Lefranc, E. Y. Amela, C. Chevreau, B. N. Bui et al., A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group, Br. J. Cancer, vol.109, pp.909-914, 2013.

F. K. Kommoss, K. T. Chang, D. Stichel, A. Banito, D. T. Jones et al., Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications, J. Pathol. Clin. Res, vol.6, p.28, 2020.

E. Z. Keung, M. Burgess, R. Salazar, E. Parra-cuentas, J. Rodrigues-canales et al., Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab, Clin. Cancer Res, vol.26, pp.1258-1266, 2020.

X. Ma, J. Wang, J. Wang, C. X. Ma, X. Gao et al., The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis, Oncotarget, vol.8, pp.4062-4078, 2017.

Z. Wang, M. D. Gearhart, Y. Lee, I. Kumar, B. Ramazanov et al., A Non-canonical BCOR-PRC1.1 Complex Represses Differentiation Programs in Human ESCs, Cell Stem Cell, vol.22, pp.235-251, 2018.

C. R. Antonescu, Y. Sung, C. Chen, L. Zhang, H. Chen et al., Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors-molecular characterization shows genetic overlap with endometrial stromal sarcoma, Genes Chromosomes Cancer, vol.53, pp.183-193, 2014.

Q. Zhang, K. Zhao, Q. Shen, Y. Han, Y. Gu et al., Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6, Nature, vol.525, pp.389-393, 2015.

V. I. Gaidzik, P. Paschka, D. Späth, M. Habdank, C. Köhne et al., TET2 mutations in acute myeloid leukemia (AML): Results from a comprehensive genetic and clinical analysis of the AML study group, J. Clin. Oncol, vol.30, pp.1350-1357, 2012.

A. J. Ainsworth, N. K. Dashti, T. Mounajjed, K. J. Fritchie, J. Davila et al., Leiomyoma with KAT6B-KANSL1 fusion: Case report of a rapidly enlarging uterine mass in a postmenopausal woman, Diagn. Pathol, vol.14, 2019.

I. Panagopoulos, L. Gorunova, B. Bjerkehagen, and S. Heim, Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21), PLoS ONE, vol.10, 2015.

J. G. Tate, S. Bamford, H. C. Jubb, Z. Sondka, D. M. Beare et al., COSMIC: The Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res, vol.47, pp.941-947, 2019.